Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Serendipity Impact VC, based in the United States, focuses on advancing technologies in mental and neuro health. The firm invests at pre-seed, seed, and seed-plus stages, leveraging strong ties to the Israeli innovation ecosystem. Their portfolio includes notable companies and they actively engage with founders to develop scalable solutions.
This firm invests exclusively in technological solutions for mental and neuro health, targeting early-stage opportunities. They provide mentorship and build networks of clinicians and regulatory experts to help founders develop market-ready solutions. Investment sizes and specific check amounts are not disclosed.
Notable portfolio companies include Visionsense, acquired by Medtronic; Joy Ventures, focused on neuro-wellness; YU Innovation Lab, a launchpad for Israeli startups in NYC; and HealthYA Ventures, an early-stage HealthTech fund.
Submit your pitch through their form at serendipity-vc.com.
Yes, Serendipity Impact VC often leads investment rounds, particularly in their focus areas of mental and neuro health.
The firm is open to follow-on investments, especially if the startup aligns with their focus on mental and neuro health technologies.
The specific size of their current fund is not publicly disclosed, but they actively invest in early-stage companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.